Intragastric Balloon Market Research Report By Procedure Type (Placement, Removal, Replacement), By Product Type (Saline-Filled Balloons, Gas-Filled Balloons, Dual-Filled Balloons), By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics), By Application (Weight Loss, Obesity Treatment, Non-Surgical Option) andBy Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa)- Forecast to 2035

Intragastric Balloon Market Overview

As per MRFR analysis, the Intragastric Balloon Market Size was estimated at 2.13 (USD Billion) in 2023.The Intragastric Balloon Market Industry is expected to grow from 2.22(USD Billion) in 2024 to 3.5 (USD Billion) by 2035. The Intragastric Balloon Market CAGR (growth rate) is expected to be around 4.24% during the forecast period (2025 - 2035).

Key Intragastric Balloon Market Trends Highlighted

The Intragastric Balloon Market is growing rapidly in the Analyst's view as a result of growing obesity and increased knowledge regarding weight-loss methods that are not surgical. There is growing interest in non-surgical procedures as patients start to look for non-surgical alternatives to bariatric surgery. Intra gastric balloons as a non-invasive procedure is gaining its popularity as it provides a temporary aiding solution that can encourage people to lose weight with a change in their lifestyle. Furthermore, regulatory approvals and technological developments of balloons are other contributors of the growth of the market. There is room to add and expand this products range especially in the developing regions which are witnessing a surge in the rate of obesity.

 There is also scope of improvement within the intra gastric balloons which would make the products more practical to use and efficient. Furthermore, as more people are becoming more conscious about their health and seeking for solutions that would improve their QOL, the correlation between weight management and health will inevitably increase the attention given to the intragastric solutions. Salt can go into partnership with healthcare providers and wellness programmes to improve availability and education on the intragastric solutions increasing business opportunities. In recent times there is a significant development towards customized medicine that is catered to a specific patient and determines an effective weight-loss solution. This shift in focus has also fostered a development on telehealth and remote engagement with patients so that continuous monitoring and support systems are enhanced.

 The future is marked by a shift towards convenience and customization. Advances in digital health technology have enabled telemedicine to assist during intragastric balloon procedures enhancing treatment outcomes. Such trends recompose the structure of the intragastric balloon market to suit the needs and wants of the consumer.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Intragastric Balloon Market Drivers

Increasing Prevalence of Obesity and Related Health Issues

The surge in obesity rates across the globe has become a critical concern, driving substantial growth in the Global Intragastric Balloon Market Industry. As more individuals seek effective weight management solutions, the demand for minimally invasive procedures like intragastric balloon therapy has escalated. The visibility of obesity-related health issues, such as diabetes, cardiovascular diseases, and certain types of cancer, continues to amplify public awareness toward the necessity of proactive weight loss interventions.Additionally, the rising focus on improving overall health and quality of life is prompting both healthcare providers and patients to explore innovative solutions available in the Global Intragastric Balloon Market Industry. The integration of technology in healthcare has further aided this change; the development of advanced, safe, and effective balloon products and the increasing number of trained specialists have made these procedures more accessible than ever.Furthermore, the association of obesity with various chronic conditions has influenced healthcare policies, encouraging insurance coverage for weight management therapies, creating a conducive environment for market growth. This multifaceted approach encompasses societal, technological, and healthcare policy shifts that collectively propel the intragastric balloon market forward while shaping future market dynamics.

Technological Advancements in Intragastric Balloon Devices

Technological innovations within the Global Intragastric Balloon Market Industry are instrumental in enhancing the efficacy and safety of balloon devices. Modern intragastric balloons are designed to be more durable, comfortable, and easier to insert and remove, significantly improving patient experience. These advancements are synonymous with the development of materials that are less likely to cause complications and allow for extended placement durations, which in turn contribute to improved weight loss outcomes.As manufacturers continue to focus on research and development, the introduction of smarter, interconnected devices that monitor patient progress will further revolutionize treatment protocols, fostering widespread acceptance and trust in these solutions.

Growing Acceptance of Non-Surgical Weight Loss Solutions

The increasing acceptance of non-surgical weight loss options among healthcare professionals and patients is significantly boosting the Global Intragastric Balloon Market Industry. Patients are increasingly inclined towards less invasive alternatives that present fewer risks compared to traditional surgical methods. This paradigm shift is underpinned by the acknowledgment of the effectiveness of intragastric balloons in facilitating long-term weight loss, further promoting their integration into standard weight management protocols.The rise of lifestyle-related health issues has also led to broader discussions about the importance of healthy weight management, thus increasing the demand for non-surgical options.

Intragastric Balloon Market Segment Insights

Intragastric Balloon Market Procedure Type Insights

The Global Intragastric Balloon Market is a significant segment of the healthcare industry focused on addressing obesity and weight management through minimally invasive procedures. Within this market, the Procedure Type is categorized into three main areas: Placement, Removal, and Replacement. In 2024, the Placement segment holds a major portion of the market with an estimated value of 1.06 USD Billion, which is projected to grow to 1.68 USD Billion by 2035, showcasing its dominance and importance in the overall landscape of weight management solutions.

The growth in the Placement area may be attributed to the rising prevalence of obesity worldwide and the increasing acceptance of intragastric balloons as an effective method for weight loss. The Removal segment, valued at 0.64 USD Billion in 2024, is anticipated to reach 1.01 USD Billion by 2035, indicating its growing importance in the procedure lifecycle as balloons need to be safely extracted after their functional period. This segment is crucial because it ensures patient safety and efficacy of weight loss procedures, thereby contributing to overall patient satisfaction and trust in intragastric balloon treatments.Finally, the Replacement category is valued at 0.52 USD Billion in the current market and is expected to rise to 0.81 USD Billion by 2035. Although it represents the smallest sector, Replacement plays a significant role for patients who might require a follow-up procedure after the initial balloon is removed. 

The replacement procedures not only help maintain weight loss results but also support ongoing patient engagement and adherence to treatment plans, creating additional opportunities for healthcare providers. Overall, the segmentation within the Global Intragastric Balloon Market highlights the critical roles that Placement, Removal, and Replacement procedures play in addressing obesity challenges, with each category demonstrating its relevance and contributions to market growth through patient-centered solutions.As the market continues to evolve, understanding these Procedure Type dynamics will be essential for stakeholders aiming to enhance service delivery, align innovations with patient needs, and capitalize on emerging trends within the weight management landscape.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Intragastric Balloon Market Product Type Insights

The Global Intragastric Balloon Market has shown remarkable progress, with the market expected to reach 2.22 billion USD in 2024 and continue to expand through the following years. Within the Product Type segment, several categories elaborate the market's structure, including Saline-Filled Balloons, Gas-Filled Balloons, and Dual-Filled Balloons. Saline-Filled Balloons often dominate the market due to their effectiveness and safety, appealing greatly to both healthcare providers and patients. Gas-Filled Balloons are also significant, favored for their ease of use and effectiveness in achieving weight loss goals, thus contributing to market growth.

Dual-Filled Balloons present a unique offering by combining benefits from both saline and gas-filled categories, capturing the attention of diverse patient demographics and presenting new opportunities within the market. The overall Global Intragastric Balloon Market data reflects a growing awareness of obesity management solutions, which drives demand for these products. However, challenges such as regulatory concerns and competition from alternative weight loss methods continue to shape the landscape. Understanding the Global Intragastric Balloon Market segmentation is vital as it helps identify trends, opportunities, and growth drivers that influence the industry's future direction.

Intragastric Balloon Market End User Insights

The Global Intragastric Balloon Market has shown substantial growth, especially in the End User segment, which comprises various healthcare settings, including hospitals, ambulatory surgical centers, and specialty clinics. As of 2024, the market is valued at approximately 2.22 USD billion, reflecting the increasing prevalence of obesity and a growing awareness of non-surgical weight loss methods. Hospitals play a crucial role, maintaining a strong presence in providing comprehensive surgical and supportive care for patients, thus driving demand.Ambulatory surgical centers have emerged as significant due to their ability to offer same-day discharge for patients, enhancing convenience and efficiency in treatment, while specialty clinics focus on tailored care, offering a personalized approach that appeals to patients seeking specific services. 

The combination of rising obesity rates and the effectiveness of intragastric balloons has potentially led to increased adoption in these healthcare settings. Furthermore, advancements in balloon technology and improved patient outcomes contribute to this market's expansion, with opportunities emerging for innovative solutions within these significant user categories, ultimately enriching the Global Intragastric Balloon Market revenue.The overall market growth underscores the diversification of user environments where these medical devices are employed.

Intragastric Balloon Market Application Insights

The Application segment of the Global Intragastric Balloon Market showcases a well-defined landscape primarily focusing on Weight Loss, Obesity Treatment, and Non-Surgical Options. By 2024, the market is expected to reach a valuation of approximately 2.22 USD Billion, reflecting a growing demand for innovative solutions in addressing obesity and weight management. Weight Loss applications are gaining prominence as they cater to individuals seeking effective and less invasive alternatives to traditional weight loss methods. The significance of Obesity Treatment within the market lies in its potential to alleviate health risks associated with excessive weight, thereby driving its increasing adoption.Non-Surgical Options continue to dominate the market due to their appeal for patients seeking minimal downtime and discomfort compared to surgical interventions. 

The growing health consciousness among consumers and the advancement of intragastric balloon technology contribute to an expanding market growth, while challenges such as regulatory approvals may influence market dynamics. Overall, the various applications represent crucial components in the Global Intragastric Balloon Market data, emphasizing its role in enhancing overall health and wellness.

Intragastric Balloon Market Regional Insights

The Global Intragastric Balloon Market exhibits significant revenue potential across various regions, with North America leading the way, anticipated to reach 0.92 USD Billion in 2024 and growing to 1.46 USD Billion by 2035. This region holds a majority share due to high healthcare expenditure and increasing obesity rates, driving demand for innovative weight management solutions. Europe follows as another major market, with valuations of 0.68 USD Billion in 2024 and 1.08 USD Billion in 2035, supported by a growing focus on minimally invasive procedures.

The APAC region is also important, valued at 0.48 USD Billion in 2024 and projected to increase to 0.76 USD Billion by 2035, driven by rising awareness and acceptance of intragastric balloon treatments. South America and MEA make up smaller portions of the market, valued at 0.08 USD Billion and 0.06 USD Billion respectively in 2024, emphasizing the emerging nature of these markets in the Global Intragastric Balloon Market industry. Overall, these regional insights help in understanding the market dynamics and delineate growth opportunities for stakeholders looking to penetrate or expand in these diverse environments.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Intragastric Balloon Market Key Players and Competitive Insights

The Global Intragastric Balloon Market has been experiencing significant growth in recent years, driven by the increasing prevalence of obesity and the rising awareness regarding weight loss solutions among consumers. This market is characterized by intense competition, as several key players strive to innovate and offer state-of-the-art products that cater to the diverse needs of patients. Competitive dynamics in this market feature a mix of established companies and emerging firms, each vying for a larger market share by focusing on product differentiation, extensive marketing strategies, strategic partnerships, and clinical research to validate their offerings.

The landscape is influenced by regulatory approvals, technological advancements, and shifting consumer preferences toward non-invasive weight loss options. As the market continues to expand, players are also investing in improving patient outcomes through better design and functionality of the intragastric balloons, aligning their products with the latest healthcare standards and guidelines.Evoke Surgical has emerged as a formidable player in the Global Intragastric Balloon Market, emphasizing its commitment to innovation and quality. The company is known for developing advanced intragastric balloon systems that are not only effective but also designed with patient comfort in mind. Evoke Surgical differentiates its offerings through superior technology that enhances the safety and efficacy of weight management procedures. 

Their focus on research and development allows them to stay ahead of the curve in terms of meeting industry standards and addressing consumer needs. Additionally, their robust marketing strategies and strong partnerships with healthcare providers help bolster their market presence. By continuously engaging in clinical trials and studies, Evoke Surgical strives to validate the effectiveness of its products, further solidifying its reputation and trust among practitioners and patients alike.G S Medical is another key competitor in the Global Intragastric Balloon Market, recognized for its range of high-quality and innovative products tailored for weight loss interventions. The company leverages its extensive experience in the medical device sector to deliver clinically effective solutions that cater to obesity management. 

G S Medical's intragastric balloons are designed with the latest technology to maximize patient safety and comfort during procedures. The company's strong emphasis on quality assurance and compliance with regulatory standards enhances its market credibility. Moreover, G S Medical actively engages in strategic collaborations with healthcare institutions and professionals to expand its distribution channels and market reach. This approach enables G S Medical to effectively respond to consumer demands and maintain a competitive edge in the evolving landscape of obesity treatment. The company's commitment to ongoing research and adaptation to market trends favorably to capitalize on emerging opportunities within the Global Intragastric Balloon Market.

Key Companies in the Intragastric Balloon Market Include

• Evoke Surgical


• G S Medical


• Spatz FGIA


• Allergan


• Novartis


• Ethicon


• BMI Healthcare


• ReShape Lifesciences


• Intragastric Balloon


• Bariatric Innovations


• Gastric Balloons Inc


• Endalis


• Apollo Endosurgery


• Medtronic


• Obalon Therapeutics

Intragastric Balloon Market Industry Developments

Recent developments in the Global Intragastric Balloon Market have demonstrated significant growth, with companies such as Apollo Endosurgery and Ethicon expanding their market presence through innovative product launches and clinical trials that highlight the effectiveness of intragastric balloons for weight management. Meanwhile, Evoke Surgical and G S Medical are making strides in introducing advanced technologies to enhance patient outcomes. The competitive landscape is evolving, with ReShape Lifesciences and Medtronic focusing on collaborations aimed at improving treatment protocols. In terms of mergers and acquisitions, there have been notable activities, although specifics regarding major partnerships involving Allergan or Novartis remain scarce. Gastric Balloons Inc and Bariatric Innovations are also facing growing interest from investors, reflecting a bullish sentiment towards the intragastric balloon segment. The increasing prevalence of obesity and the rising demand for non-invasive solutions contribute to the market's robust growth trajectory, with health institutions and consumers alike embracing these interventions as viable options for weight loss. Additionally, ongoing research and development efforts are set to enhance the effectiveness and safety of these devices, driving further adoption across various demographics.

Intragastric Balloon Market Segmentation Insights

Intragastric Balloon MarketProcedure TypeOutlook

• Placement


• Removal


• Replacement

Intragastric Balloon MarketProduct TypeOutlook

• Saline-Filled Balloons


• Gas-Filled Balloons


• Dual-Filled Balloons

Intragastric Balloon MarketEnd UserOutlook

• Hospitals


• Ambulatory Surgical Centers


• Specialty Clinics

Intragastric Balloon MarketApplicationOutlook

• Weight Loss


• Obesity Treatment


• Non-Surgical Option

Intragastric Balloon MarketRegionalOutlook

• North America


• Europe


• South America


• Asia Pacific


• Middle East and Africa